Infectious diseases doctors in Tashkent

PCR for chlamydia (blood) from 165 000 UZS PCR for ureaplasma (blood) from 165 000 UZS PCR for mycoplasma genitalium (blood) from 165 000 UZS PCR for mycoplasma hominis (blood) from 165 000 UZS PCR for cytomegalovirus (blood) from 165 000 UZS PCR for herpes HSV 1/2 (blood) from 165 000 UZS PCR for Toxoplasma (blood) from 165 000 UZS Toxoplasma: IgM and IgG antibodies from 75 000 UZS Cytomegalovirus: IgM and IgG antibodies from 75 000 UZS Herpes type II: IgM and IgG antibodies from 75 000 UZS HSV 1/2: IgM antibodies from 75 000 UZS Rubella: IgM and IgG antibodies from 85 000 UZS Rubella antibody avidity from 145 000 UZS HBsAg (hepatitis B, ELISA screening) from 45 000 UZS Bloodborne infections during surgery (HIV+RW+HbsAg+HCV) from 170 000 UZS HBsAg (hepatitis B) by CLIA from 95 000 UZS HIV (anti-HIV 1/2) from 45 000 UZS RW (Wassermann reaction, syphilis) from 45 000 UZS Anti-HCV (hepatitis C, ELISA screening) from 45 000 UZS Anti-HCV (hepatitis C) by ICL method from 95 000 UZS Hepatitis B virus DNA (PCR, quantitative) from 310 000 UZS Hepatitis C virus RNA (PCR, quantitative) from 310 000 UZS Anti-HBcore (IgM and IgG) from 90 000 UZS Anti-HBe from 190 000 UZS Hepatitis A: anti-HAV IgM and IgG from 90 000 UZS Hepatitis D (anti-HDV total) from 95 000 UZS Procalcitonin (marker of severe infection and sepsis) from 350 000 UZS C-reactive protein (qualitative) from 65 000 UZS Hepatitis E: anti-HEV IgM and IgG from 95 000 UZS Procalcitonin (extended study) from 385 000 UZS C-reactive protein (quantitative) from 110 000 UZS COVID-19 rapid test (antigen) from 175 000 UZS PCR for COVID-19 from 345 000 UZS Antibodies to COVID-19 (IgG/IgM, quantitative) from 310 000 UZS